For adults at high risk of cardiovascular disease, lowering systolic blood pressure to below 120 mm Hg results in consistent health benefits regardless of whether they have diabetes or a prior stroke.
See the scientific wording
In adults with high cardiovascular risk, targeting systolic blood pressure below 120 mm Hg provides a consistent benefit across subgroups including those with diabetes and those with prior stroke, with no statistically significant heterogeneity in effect (p>0.05 for interaction).
Very strong evidence
Randomized trialsOne good-quality study supports this claim.
What the research says
1 study reviewedSupporting (1)
Randomized Controlled TrialHuman
For people at high risk of heart problems, lowering blood pressure to under 120 helped prevent heart attacks and strokes just as much whether they had diabetes or had a stroke before, compared to those who didn’t. The study found no difference in how well the treatment worked across these groups.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Lowering blood pressure reduces force on artery walls, which prevents damage to the inner lining of blood vessels and stops dangerous buildups from breaking loose, thereby preventing heart attacks and strokes.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
For adults at high risk of cardiovascular disease, lowering systolic blood pressure to below 120 mm Hg results in consistent health benefits regardless of whether they have diabetes or a prior stroke.
Mechanism
1 studyLowering blood pressure to under 120 mm Hg reduces the force on artery walls, which keeps the inner lining healthy and prevents dangerous buildups from breaking off. This happens the same way whether a person has diabetes or had a stroke before, because it's about physical pressure, not underlying conditions.
Lowering blood pressure reduces force on artery walls, which prevents damage to the inner lining of blood vessels and stops dangerous buildups from breaking loose, thereby preventing heart attacks and strokes.
Systolic blood pressure below 120 mm Hg reduces mechanical stress on arterial wallshear walls
Reduced arterial wall stress decreases endothelial cell activation and inflammatory signaling
Lower endothelial activation stabilizes atherosclerotic plaques by reducing matrix metalloproteinase activity and smooth muscle cell apoptosis
Plaque stabilization prevents rupture and subsequent thrombus formation in coronary and cerebral arteries
Evidence from Studies
Supporting (1)
Community contributions welcome
For people at high risk of heart problems, lowering blood pressure to under 120 helped prevent heart attacks and strokes just as much whether they had diabetes or had a stroke before, compared to those who didn’t. The study found no difference in how well the treatment worked across these groups.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Systolic Blood Pressure Targets Below 120 mm Hg in High-Risk Cardiovascular Populations with Diabetes or Prior Stroke
Population: Adults with high cardiovascular risk including those with diabetes and prior stroke; Intervention: Systolic blood pressure target below 120 mm Hg; Comparator: Systolic blood pressure target of 130-140 mm Hg; Outcome: Composite cardiovascular events, all-cause mortality; Duration: Minimum 3 years; Analysis: Subgroup analysis by diabetes status and prior stroke history.
SPRINT Subgroup Analysis: Randomized Trial of Intensive vs Standard Blood Pressure Control in High-Risk Adults with Diabetes or Prior Stroke
Population: Adults with high cardiovascular risk and either diabetes or prior stroke; Intervention: Intensive blood pressure control (<120 mm Hg); Comparator: Standard blood pressure control (<140 mm Hg); Outcome: Major adverse cardiovascular events; Duration: Minimum 3 years; Design: Double-blind, stratified randomization by subgroup status.
Longitudinal Cohort Study of Blood Pressure Targets and Cardiovascular Outcomes in High-Risk Adults with Diabetes or Prior Stroke
Population: Adults with high cardiovascular risk and diabetes or prior stroke; Exposure: Systolic blood pressure maintained below 120 mm Hg; Comparator: Systolic blood pressure maintained at 130-140 mm Hg; Outcome: Incident cardiovascular events over 5+ years; Design: Prospective, adjusted for confounders including medication adherence and comorbidities.
Case-Control Study of Prior Blood Pressure Control Levels in High-Risk Adults with and without Cardiovascular Events
Population: High-risk adults with cardiovascular events (cases) vs. matched controls without events; Exposure: Historical systolic blood pressure levels below 120 mm Hg; Comparator: Systolic blood pressure levels above 120 mm Hg; Design: Retrospective, matched for age, diabetes status, and prior stroke history.
Cross-Sectional Survey of Blood Pressure Levels and Cardiovascular Risk Markers in Adults with Diabetes or Prior Stroke
Population: Adults with high cardiovascular risk including diabetes or prior stroke; Exposure: Current systolic blood pressure below 120 mm Hg; Comparator: Systolic blood pressure above 120 mm Hg; Outcome: Biomarkers (e.g., hs-CRP, NT-proBNP); Design: Single-timepoint measurement, no follow-up.